Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial (2020)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 396
Parent Publication: LANCET
Issue: 10255
ISSN: 0140-6736